Trial NCT00649584

View at ClinicalTrials.gov 
Org. Study IDs: SG035-0002

Last trial update was posted on 2014-12-18

MeSH Interventions

Brentuximab Vedotin Gemcitabine

MeSH Conditions

Hodgkin Disease Lymphoma Lymphoma, Large-Cell, Anaplastic Lymphoma, Non-Hodgkin

Other Conditions

Disease, Hodgkin

Stopping Reasons

Sponsor decision not to enroll cohorts of combined SGN-35 and gemcitabine therapy.

Limitations And Caveats

N/A

Result Publications


Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID